Company Introduction
Dongkook Pharmaceutical's spirit to step up to challenges results from our resilience
in overcoming uphill battles and passion in unexplored areas.
50th Anniversary History Hall
The footstep of Dongkook who has walked to pursue the respect of life
and the healthy life of people based on the company philosophy of creation, unity and trust.
2017 – Current
Toward the top total healthcare group in Korea
2018. 09. 03
Began the construction of a dedicated factory for
the extraction of natural products
2017. 05. 01
Founded Dongkook Life Science
2009 – 2016
Became the top innovative pharmaceutical company with continuous quantum growth
2016. 12. 14
Selected for 1st Class Enterprise at 2016
Korea Consumer Satisfaction Evaluation (KCSE)
2012. 09. 03
Launched Healthcare Business Division
2012. 06. 18
Selected for Innovative Pharmaceutical Company
2011. 03
Teicoplanin acquired the Certificate of Suitability from
EDQM (European Directorate for the Quality of Medicines)
2010. 11. 30
Received the Export Tower Award of 30 Million Dollars
2002 – 2008
2nd Stage Management Era, Established a basis for advanced pharmaceutical company
2008. 11. 30
Received the Export Tower Award of 20 Million Dollars
2007. 05. 29
Listed in KOSDAQ
2007. 04
Jincheon Central R&D Center moved to
Gyeonggi Bio-Center at Suwon, Gyeonggi do
2005. 05. 23
Selected by the MOTIE for the advanced
manufacturing technology & research center (ATC)
2004. 11. 30
Received the Export Tower Award of 10 Million Dollars
2002. 11
Received the Export Tower Award of 5 Million Dollars
1994 – 2001
Creative enterprise culture, flourished by the development of new drug
2000. 12
Received the SMEs Award
(Director’s Award in the field of Technical Development)
1999. 12
Received the Export Tower Award of 1 Million Dollars
1998
Acquired KGMP Certificate for the lyophilization injection for Plant 3
Developed Iopamidol and Pamiray for the first time in Asia
1997
Acquired KGMP of injection formula for Plant 3
1996. 05
Acquired the certificate of Propofol KT (domestic new technology)
1995. 11. 16
Acquired the certificate of Minocline Oral Strip KT
(Domestic new technology)
1994. 07. 08
Acquired the certificate of KGMP for Plant 3
1982 – 1993
Challenge to become the top pharmaceutical company, launched Dongkook Pharmaceutical
1993. 07. 13
Completed the construction of Plant 3
1992. 10. 15
Dedicational ceremony for the complete construction of
Plant 2 & release of sterile injection for sales
(Prefilled Syringe System introduced)
1992. 10. 01
Head Office moved to Dongkook Building at Daechi-dong Gangnam-gu
1992. 07. 02
Acquired the certificate of KGMP for Plant 2
1991. 12. 30
Acquired the certificate of KGMP for Plant 1
1991. 03. 31
Completed the construction of Injection Factory (Plant 2),
established a Prefilled Syringe System for the first time in Korea
1989. 05
Established a Central R&D Center inside Plant 1
1986. 10. 03
Release of Oramedy Ointment for sales
1985. 04
Began the construction of API Synthesis Factory
(Hoejuk-ri, Gwanghyewon-myeon, Jincheon-gun)
1982. 03
Changed the company name to Dongkook Pharmaceutical Co., Ltd
1968 – 1981
Root of Dongkook Pharmaceutical, UEC Co., Ltd was born
1978
Self-manufacturing of Madecassol
Succeeded in the synthesis of titrated extracted of unsaponifiable
extract of Zea Mays L., manufactured finished drug
1978. 02
Merged Joongwon New Drug to UEC Co., Ltd
1974
Imported and sold Insadol Tablet from Laroche Navarron of France
1974. 06. 16
Founded Joongwon New Drug Company
1972. 02
Acquired the medicinal production factory (Taemyeong Drug)
1968. 10. 15
Founded UEC Co., Ltd
Imported and sold Medecassol from Laroche Navarron of France
